Background: Obsessive-compulsive disorder (OCD) segregates in families. It follows a complex model of genetic transmission, which involves the influence of several small effect genes interacting with the environment. Methods: A systematic review of genetic association studies in OCD was performed. Articles published until 2012 were searched in the databases PubMed, Embase and ScieLO using the terms of MeSH and its associates or synonyms for "obsessivecompulsive disorder", "gene" and "genetic association studies". Results: We selected 105 papers and described their main results grouped as genes related to: serotonin, dopamine, glutamate, GABA, white matter, immune system, hormones and other genes. Discussion: There is high variability between findings of association studies among the several candidate genes studied in OCD. Glutamate-related genes are promising candidates for OCD, but there is no conclusive association between any of the candidate genes studied and OCD. Association studies with large sample size, evaluation of more homogeneous subgroups of phenotype and meta-analyses are still needed.
Introduction
Obsessive-compulsive disorder (OCD) is the fourth most common psychiatric disorder with a lifetime prevalence between 2.0% and 2.5% 1 . According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria, OCD is characterized by obsessions and/or compulsions. These obsessions / compulsions occur for at least an hour a day, cause functional interference and significant distress or social impairment 2 . OCD is a chronic disorder and manifests regardless of sex, race, intelligence, marital status, socioeconomic status, religion or nationality. The cross-cultural studies show that the OCD symptoms are similar in different population and cultures 3 , supporting the idea that biological and genetic factors can contribute to its etiology. Although psychological theories have grounded the emergence of the OCD concept 4 there is increasing evidence that it is mediated by a genetic-environmental interaction. In fact, the involvement of genetic factors in the etiology of OCD has been emphasized since the first descriptions of OCD 5 . Studies in Human Genetics Psychiatric genetics seeks to understand how biological and environmental factors interact to cause a specific psychiatric disorder. The study designs in human genetics assessing etiologic factors of psychiatric disorders are divided into two groups: genetic-epidemiological studies and molecular genetic studies.
Genetic-epidemiological studies
Genetic-epidemiological psychiatry is a science that deals with "causes, distribution and control of disease among family groups and with genetic causes of diseases in populations" 6 . Genetic epidemiology uses as methodology the family studies, twin or adoption studies, or segregation analyses.
Family studies
Uses the case-control study design. Thus, there is a comparison between the frequency of the disorder in relatives of patients with the investigated phenotype (case probands) and the frequency of that disorder in relatives of individuals who do not have the investigated phenotype (control probands). If the frequency of the studied phenotype is significantly higher in the group of case probands' relatives, it can be said that there is familial aggregation 6 . A meta-analysis of studies in OCD families, involving 312 probands and their 1209 first-degree relatives, found a cumulative risk of 8.2% among "case" relatives and 2% among "control" family members, with an odds ratio of 4 (95% CI = 2.2, 7.1) to present OCD 7 . Twin studies compare the concordance for certain phenotypes between monozygotic (MZ), with the correlation observed between dizygotic (DZ) twins. The assumption is that MZ and DZ twins suffer similar environmental influence; however MZ twins share 100% of genome, while DZ twins share about 50%. Thus, in phenotypes more influenced by the environment, the concordance rates between MZ and DZ were similar; whereas in phenotypes more influenced by a genetic component, the MZ concordance rate would be higher than in DZ 8 . Furthermore, twin studies also allow us to estimate heritability (h2), that is, the size of the genetic effect in determining the studied phenotype. Data from 28 twin studies in OCD have shown that obsessive-compulsive symptoms (OCS) have genetic contributions with heritability rates of 45% to 65% in children and 27% to 47% in adults 9 .
Adoption studies
Allow greater separation between genetic and environmental factors in the disorder etiology, since children do not share the home with their biological parents. Its main limitation is that the homes that embrace the adopted children do not represent higher risk environments (e.g., environments of extreme poverty and deprivation) 8 . Generally adoption studies assess the history of mental disorders in the biological family and correlate with psychosocial protective or risk factors in the adoptive family 8 . As far as we know, there is no adoption study in OCD.
Segregation analysis
Assesses whether the transmission of a studied phenotype, over the family generations, can be explained by a Mendelian genetic model. Some of the models evaluated by genetic segregation analysis are: no transmission, autosomal dominant, autosomal recessive, polygenic (multiple genes of small effect); multifactorial or mixed (multiple genes of small effect added to environmental influences). The most accepted segregation model for OCD is the complex or mixed model, which involves the influence of many genes of small effect interacting with the environment 6 .
Molecular genetic studies
Several studies in genetic epidemiology have been consistent in stating that OCD is a familial disorder. With the advent of modern molecular biology techniques, there has been growing interest in identifying which genes are involved in OCD etiology. Most genetic studies in OCD evaluate its association with genes involved in OCDrelated brain circuits.
Linkage studies
Evaluate whether a particular genetic marker with known location co-segregates with the studied phenotype over generations. When two loci, located on the same chromosome, are very close to each other, they tend to be transmitted together (linked) as there are low odds of recombination between homologous chromosomes (crossing over). So, if the affected family members always inherit the studied genetic marker, the gene responsible for the disease is probably located near the marker. The main limitation of the study is the need to evaluate several family generations, with multiple affected members, in "complex" disorders such as OCD 6 .
Association studies
Are designed to detect specific genes involved in a disorder. With the case-control design, whether there is a significant difference in an allelic variant distribution among affected (cases) and unaffected individuals (controls) 10 is evaluated. The main limitation of the case-control association analysis is population stratification bias, which is when cases and controls are not ethnically matched. Family-based association studies, comparing the proband with the own biological parents, a "trio", controls the population stratification bias. These analyses, called Transmission Disequilibrium Test (TDT) and the Haplotype Relative Risk (HRR) 6 , compare the frequency of transmitted and untransmitted alleles from parents to the proband.
Several markers covering the entire genome can be evaluated in a Genomewide association study. However, most association studies evaluate polymorphisms located in candidate genes. Polymorphism is a DNA sequence variation found that is present in more than 1% of the population. The polymorphisms may be by exchange of one nitrogenous base (single nucleotide polymorphism -SNP) or by varying the number of repetitions of a sequence of bases in a particular locus (variable number of tandem repeats -VNTR). The choice of a candidate gene to be investigated on a particular disorder can be based on clinical features or pathophysiology.
This review aims to present the results of studies of the association between candidate genes and OCD.
Methods
We performed a systematic review by searching for articles published up to May 4, 2012 in databases: PubMed, Embase and SciELO using MeSH terms, its associates or synonyms for "obsessive-compulsive disorder", "gene" and "genetic association studies".
Each term results) and later the three searches were combined using the word "AND" resulting in 202 references in PubMed, 49 references in Embase and 7 references in SciELO. References were sent to the reference management program EndNote® and duplicates were discarded. References were selected and two independent researchers (ASS and RPL) assessed the full texts based on the inclusion criteria, which are: 1) Original studies or reviews about the association with candidate genes 2) The probands were required to meet criteria for DSM III or DSM IV to obsessive-compulsive disorder, 3) Studies should be written in English, Portuguese or Spanish (Figure 1 ): flowchart of search and selection of articles. The list of references of selected studies was examined to evaluate studies not found in the database.
Results
We selected 105 studies whose main findings are summarized below.
Genes related to serotonin
Gene serotonin transporter (SLC6A4, 5-HTT, SERT, 5HTTLPR) Chromosome: 17; location: 17q11.1-q12
The serotonin transporter gene is an important candidate gene, since it represents the primary target for serotonin reuptake inhibitors (SRI). Hanna et al. reported an association between blood levels of serotonin and specific genotypes of 5HTT in families of patients with OCD 11 .
A polymorphic region, comprising repeated elements 16, is described next to the start of zone 5HTT gene transcription, the 5-HT-TLPR polymorphism is an insertion or deletion of 44-bp elements involving repeated 6 to 8 times generating two functional alleles : A short allele (S) and the long allele (L) 12 . However, Hu and co-workers reported that 5-HTTLPR polymorphism is functionally triallelic, resulting from the substitution of A for G in the G allele 13 . Other polymorphisms of this gene that correspond to a variable number of tandem repeats (VNTR) in the 17 base pair (bp) are termed the VNTR STin2 and involve different alleles 14 . Studies of the gene 5HTT are described in table 1.
Serotonin receptor type 2A (HTR2A, 5-HT2A) Chromosome: 13; location: 13q14-q21
Evidence suggests that an action of the serotonin 2A receptor in OCD run reports of benefit in the use of hallucinogens (potent stimulants of 5HT2A) and the tendency of clozapine trigger SOC in patients with schizophrenia 15 . The two most studied polymorphisms in OCD are -1438 A/G and T102C. Some studies show an association between OCD and AA allele polymorphism -1438 G/A in women 16, 17 and in a sample of children and adolescents 18 . These results were not replicated in other studies 15, 19 . Liu et al. studied a sample of 103 Chinese trios and found a significant association between OCD and 5HT2A polymorphism-1438G/A (p = 0.0389), and a transmission disequilibrium in the late-onset group (p = 0.0132) and in the male group (p = 0.0255) 20 . Regarding the T102C variant, several studies found no significant association with OCD 15 
Serotonin receptor type 1B (HTR1B, 5HT1B)
Chromosome: 6; location: 6q13
The beneficial effects of atypical antipsychotic drugs and hallucinogens in 5HT1B were seen in some OCD patients, suggesting that this receptor may be involved in the neurobiology of OCD.
World et al. found a preferential transmission of the G861 allele for OCD 24 and confirmed these findings in a longitudinal study 25 . Camarena et al. also found a preferential transmission of the variant G861 C861 compared to the group with the highest scores of the YBOCS (Yale-Brown Obsessive Compulsive Scale), although no association was found with OCD 26 . Liu et al. found an association of this gene with early onset OCD (p = 0.0389) 20 . Meanwhile, other studies have two negative findings 27, 28 . Preliminary findings of an association between allele G861 and symptoms of order/arrangement/symmetry let the suggestion for more refined phenotypic analyses in genetic studies 29 .
Receptor 5-hydroxytryptamine (serotonin) type 2C (HTR2C, 5HT2C)
Chromosome: X; location: Xq24
Chronic treatment of OCD with SSRIs may result in reduced dopamine transmission through activation of mesocorticolimbic 5HT2C, which may represent an important event for the therapeutic efficacy of SSRIs 30, 31 . Study in mice, which presented 5HT2C gene deletion, showed similar behavior to compulsive symptoms 32 . Tsaltas and co-workers showed exacerbation of SOC after administration of m-CPP (5HT2C agonist) 33 . Two studies of the association between a structural variant in the N-terminal extracellular region of the receptor and the 5HT2C TOC findings were negative 34, 35 . This variant resulting from the substitution of the amino acid cysteine for serine at position 23 36 , but does not have a defined function 34, 37 .
Tryptophan hydroxylase 1 (TPH1)
Chromosome: 11; location: 11p15.3-p14
Tryptophan hydroxylase (TPH) is an important step in the synthesis of 5HTT, and in this way is an important candidate gene. There are two forms of expression: TPH1 and TPH2.
The TPH1 is detected in blood and peripherally in the duodenum, but is not found in the brain. Two association studies found no significant findings between this gene and OCD 28, 37 .
Tryptophan hydroxylase 2 (TPH2)
Chromosome: 12; location: 12q21.1
The TPH2 is detected exclusively in the brain. One study found an association between this gene and early-onset OCD 38 . A Brazilian study with 107 patients and 214 controls found no association between the 8 SNPs evaluated in the TPH2 gene and OCD, but found higher prevalence of T-C-T (rs4448731, rs4565946, rs10506645) e C-A-T (rs4565946, rs7955501, rs10506645) haplotypes among OCD patients 39 . Among the most studied genes are the genes of the serotonin transporter (5-HTT) and its promoter region (5-HTTLPR). A recent meta-analysis assessed the studies with the 5-HTT gene, 5-HTTLPR, HTR1B, HTR2A and HTR2C in OCD and found that the association between OCD and 5HTTLPR polymorphism, when considered its 3 allele (OR: 1.251, 95% CI: (1.048 -1.492), p = 0.001), and two polymorphisms of the 5-THR2A rs6311 and 6313 (OR: 1.219, 95% CI: (1.037 to 1.433), p = 0.002) were statistically significant, strengthening its possible contribution in the etiology of OCD 40 .
Dopamine related genes
The serotonergic system has many interrelationships with other neuronal circuits and neurotransmitters 41 . Dopamine plays an important role in the pathophysiology of OCD 42 and is involved in an interaction with the dopaminergic system in the fronto-thalamic-base ganglion 43 . Such modulation of dopamine transmission made by SSRIs indirectly influences the development and OCD 43 . Pharmacological studies have found that dopamine antagonists in combination with SSRIs were effective in treating OCD. Animal studies have found that the use of dopamine agonists induces stereotypic movements similar to some SOC 44 .
Dopamine transporter gene (DAT1 or SLC6A3)
Chromosome: 5; location: 5p15.3
The dopamine transporter gene has a central role in the removal of midbrain dopamine synapses. The diffusion and uptake of dopamine by DAT1 changes the magnitude, duration, and spatial configuration of the receptor activation induced by the transmitter, thereby modifying dopaminergic neurotransmission 15 . Mice with deletion of DAT sequential display stereotypic behaviors 45 ; similar to those observed in basal ganglia disorders such as OCD and Tourette syndrome. DAT1 has a VNTR polymorphism in the 40bp repeat having 3 to 11 repetitions in the 3 "untranslated" that can influence gene expression and protein levels in brain DAT1 46 . The studies that investigated the association between DAT and TOC were negative findings 47, 48 (Table 2) .
Dopamine receptor D2 (DRD2)
Chromosome: 11; location: 11q23
The dopamine D2 receptor (DRD2) is found at high levels in the basal ganglia, which makes it a candidate gene for the pathophysiology of OCD. Although some studies have found no association between this gene and OCD, Nicolini et al. found a higher frequency of the variant in the DRD2 A2A2 OCD + tics (p = 0.008) 49 . In another study, Nicolini et al. found an association between the A allele of the DRD2 TaqIA2 (p = 0.01) and TOC and an excess of homozygotes A2A2 in OCD + tics group (p = 0.001) 50 . Denys et al. found a higher frequency of the DRD2 A2 allele only in men with OCD (p = 0.02) 51 (Table 2 ). 
Dopamine D3 receptor (DRD3)
Chromosome: 3; Location: 3q13.3
The antagonism at dopamine D3 receptor has an anxiolytic effect. The function and expression of DRD3 is decreased during stress and depression, while chronic treatment with SSRI drugs or noradrenergic DRD3 mRNA increases, offsetting the effect of the initial stress 15 . The SNP variant most studied is one that leads to the substitution of glycine for serine at codon 9 (Ser9Gly), but studies with this gene and TOC were found to be negative 49, 52 (Table 2) .
Dopamine receptor D4 (DRD4)
Chromosome: 11; location: 11p15.5
The dopamine receptor D4 (DRD4) is involved in higher brain functions, modulation of synthesis and turnover of brain dopamine. In the DRD4 gene encoding there is a VNTR polymorphism (48PB 2 to 10 tandem repeats) in the third exon, which is of great interest for psychiatric studies 53 . (Table 2) . Despite evidence of involvement of dopamine in the pathophysiology of OCD, the findings of association studies with dopaminerelated genes were mostly negative. The DRD4 gene has been the most studied in OCD with divergent findings. A recent meta-analysis found no association between OCD and the genes DAT1, DRD2, DRD3 and DRD4 40 .
Glutamate related genes
Neuroimaging studies in animal models and pharmacological studies of candidate gene association reinforce the hypothesis of the involvement of glutamate in the pathophysiology of OCD. Functional neuroimaging studies showed metabolic hyperactivity in the corticostriatal-thalamic-cortical circuits. Abnormal levels of glutamate have been reported in OCD patients, predominantly in prefrontal regions such as the orbitofrontal cortex and its projection areas in the striatum [59] [60] [61] . Glutamate levels in the CSF were also significantly higher in patients with OCD compared to controls (p = 0.014) 62 . Drugs that modulate glutamate have been recently used as boosters of pharmacological treatment of OCD in adults 63, 64 , adolescents and children 65 . In addition, glutamate-related genes as well as serotoninrelated genes had more positive association results replicated until date. Given this, the investigation of glutamatergic genes as candidates for OCD has been seen as a promising field.
Gene associated protein SAP90/PSD95-3 -SAPAP3/ DLGAP3
Chromosome: 1; location: 1p35.3-p34.1
The family of proteins associated with SAP90/PSD95 (SAPAP) is a component of postsynaptic density (PSD) that interacts with other proteins in a complex key-lock glutamatergic synapses. Results from studies in mice suggest that SAPAP3 may be involved in the pathophysiology of OCD and trichotillomania 66 . The mouse with SAPAP3 deletion self-developed facial injuries caused secondary to excessive grooming behavior, and showed dysfunction in cortical-striatal synapses. After these rats received SSRI, such behavior improved. Also, the selective striatal expression SAPAP3, mediated by lentivirus, recovered synaptic and behavioral changes of the mutant mice. The TOC and pathological grooming such as trichotillomania, have similar phenomenological characteristics 67 .
Since the Welch et al. study have shown an animal model for OCD and pathological grooming with knockout SAPAP3 gene mice, the correlate human gene (DLGAP1) began to be studied as a candidate in OCD 66 . Boardman et al. evaluated seven polymorphisms in the gene encoding the SAPAP3 in individuals with OCD (n = 172), trichotillomania (n = 45) and controls (n = 153), and found no association 68 . Among the group with OCD, early onset of the disorder and ATAT haplotype (rs11583978-rs7541937-rs6662980-rs4652867) was positively associated 68 . Bienvenu et al. evaluated 383 families and found an association between four SA-PAP3 polymorphisms and pathological grooming (onychophagia, dermatotilexomania and/or trichotillomania), but not with OCD 69 . Another study sequenced the gene SAPAP3 in 44 patients with OCD and trichotillomania, 44 OCD patients and 178 controls without trichotillomania, genotyped 6 polymorphisms in an additional sample of 281 OCD patients and 751 individuals from the general population, and noted an association between OCD and A189V polymorphism (p = 0.045) 70 .
Ionotropic glutamate receptor N-methyl D-aspartate 2B (GRIN2B, NMDAR2B)
Chromosome: 12; location: 12p12 GRIN2B is the gene which encodes one subunit of the NMDA receptor 71 . Arnold et al. studied 130 families of OCD patients and found that a haplotype consisting of two polymorphisms GRIN2B -5072T/G (p = 0.014) and 5072G-5988T was associated with susceptibility to OCD (p = 0.002) (29) . Later they evaluated 16 patients with treatment-naive OCD with magnetic resonance imaging and genotyped four polymorphisms GRIN2B (rs1019385, rs890, rs1805476 and rs1805502), and found that rs1019385 was associated with lower concentrations of glutamate in the anterior cingulate cortex 29 .
Glutamate transporter high affinity neuronal/epithelial (SLC1A1, EAAC1)
Chromosome: 9; location: 9p24
The SLC1A1, encoding the glutamate transporter high affinity neuronal/epithelial (SLC1A1, EAAC1), is a strong candidate gene is located on 9p24 region 72 . Hanna et al. studied seven families of patients with early-onset OCD, found evidence of linkage in the region 9p 73 . In a replication study, Willour et al. genotyped 50 families with OCD and found peak connecting two markers: D9S1792 (alpha p = 0.59) and D9S1813 (p = 0.006) in the 9p24 region 74 , only 0, 5 cM (< 350 kb) marker found by Hanna et al. 73 ). Studies related to the SLC1A1 gene are described in table 3. Glutamate receptor, ionotropic, kainatos 2 and 3 (GRIK2/ EAA4 and GRIK3/EAA5) Chromosome: 6, location: 6q16.3-q21, and chromosome: 1, location: 1p34-p33, respectively GRIK2 and GRIK3 contribute to the regulation of inhibitory and excitatory transmission and has important roles in physiology and plasticity of synapses 75 . There GRIK2 messenger RNA abundance in pyramidal neurons in the caudate, which are involved in the pathophysiology of OCD. Animal studies have shown that mice with deletion of GRIK2 had significant reduction of fear memory, less anxiety behaviors, more exposure to risk and aggressiveness 76 .
Genes of GRIK2 and GRIK3 were investigated in a study of 156 OCD patients, 141 controls and 124 trios, found that SNP rs2238076 allele of GRIK2 was less transmitted than expected for OCD patients (p < 0.03). Sampaio et al. also found a significant association between the SNP rs1556995 of GRIK2 (p = 0.03), and between rs1556995/ rs1417182 haplotype (p = 0.01) and OCD 77 .
The gutamatergic system has been the preferred target of the current association studies. The association with OCD was identified in five studies and a meta-analysis 78 , but another recent meta-analysis did not confirm this association 40 . A large genome scan study including 1,465 cases, 5,557 controls matched for ethnicity and 400 trios of OCD patients found an association with polymorphisms in the gene-associated protein SAP90/PSD95-1 -DLGAP-1, also related to glutamate 79 .
Gama-aminobutyric acid (GABA) related genes

GABA receptor (GABRR1)
Chromosome: 6; location: 6q13-q16.3
In the only study evaluating this gene in OCD, Zai et al. evaluated five polymorphisms in the GABA receptor type 1 (GABBR1) in 159 families and found a greater transmission of the A allele of A-7265G polymorphism in OCD 80 .
Taking into account that functional neuroimaging studies in OCD showed hyperactivity in regions of the orbitofrontal cortex, striatum, thalamus, and anterior cingulate 81 and that there is an inhibitory GABAergic pathways on glutamatergic pathways in these regions, genes related to GABA deserve to continue to be evaluated in future studies.
Other genes
Brain-derived neurotrophic factor (BDNF)
Chromosome: 11; location: 11p13 The brain-derived neurotrophic factor (BDNF) promotes regeneration of brain connectivity and proliferation during development and participates in the maintenance and plasticity of neurons even during adulthood 82 . Hall et al. evaluated the BDNF gene in 164 trios of probands with OCD and found that the Met66 allele, which alters the sequence of pro-BDNF protein was overtransmitted, and may confer a protective effect against OCD 83 . Alonso et al. evaluated SNPs in BDNF in 215 OCD patients and 342 controls, and found a significant association with a haplotype containing five val66met polymorphism markers (p = 0.006 after permutation test, which minimizes the risk of false-positive) 84 . Hemmings et al. found that Met66 allele was associated with the OCD in men with early onset OCD however, genotype Val66/Val66 was associated with more severe OCD in women 85 . Dickel et al. found no association of polymorphisms of genes SLC6A4, HTR1B, HTR2A, and BDNF in 54 trios of probands with early-onset OCD 86 . Karterberg and employees, trying to replicate these findings, evaluated 419 OCD patients and 650 controls, but found no significant association between the polymorphism val66met (rs6265) and OCD, or any dimension of OCD symptoms 87 . The studies of Mossner and employees, and Wendland et al. were also negative 88, 89 .
A meta-analysis found no association between the polymorphism and OCD val66met (OR: 1.013, 95% CI: (0.765 to 1.342), p = 0.904) 40 .
Neurotrophic tyrosine kinase receptor of (NTRK) types 1, 2 and 3
Chromosome: 1; location: 1q21-q22; chromosome: 9 location: 9q22.1; chromosome: 15; location: 15q25 (respectively) Neurotrophic tyrosine kinase receptor of type 3 (NTRK3), high affinity receptor for the neurotrophin 3 (NT-3), was evaluated by Alonso et al. in 120 OCD patients and 342 controls, and an association was found between the SNP rs7176429 (p = 0, 0001) and hoarding 90 . Alonso et al. also studied the gene of Neurotrophic tyrosine kinase receptor type 2 (NTRK2) in 215 OCD patients and 342 controls and found an intronic haplotype with a protective effect against OCD (p = 0.001) and also that an intronic SNP of NTRK2 (rs2378672) was associated with OCD in women (p < 0.0001) 84 .
Monoamine oxidase A (MAO A)
Chromosome: X; location: Xp11.3
The monoamine oxidase (MAO) is a mitochondrial enzyme that degradetes various biogenic amines, including serotonin, epinephrine, norepinephrine and dopamine. Two functional polymorphisms were studied in OCD. A polymorphism consists of a 30 bp VNTR located above the 1.2kb coding sequences of MAO-A (MAO-Au VNTR) and the other is a substitution of T for C (EcoRV) with the T allele associated with low enzymatic activity 47 . There was no association between the polymorphism and OCD EcoRV in a meta-analysis 40 . Studies on the MAO-A gene are described in table 4.
Catechol-O-methyltransferase (COMT)
Chromosome: 22; location: 22q11.21
The catechol-O-methyltransferase (COMT) is an enzyme that metabolizes catecholamines, including the neurotransmitters norepinephrine, epinephrine and dopamine 91 . The most studied polymorphism in the COMT gene is an exchange of single nucleotide (SNP) (val 158met or rs4680) G to A, which leads to an amino acid substitution of valine for methionine at codon 158 of the enzyme. This variation is associated with thermolabile form (low activity -158met allele, allele A or allele G) or thermostable (high activity -val158, allele G allele or H) of the enzyme [92] [93] [94] . A recent study has shown that OCD patients with the G allele of COMT have low levels of 3-O-methyl-DOPA, which results from methylation of L-DOPA in plasma 95 , showing that there is a decrease in the activity of the COMT enzyme in OCD patients carrying the polymorphism of low activity.
The homozygosity of allele G rs4680 of COMT polymorphism results in a decrease to half the enzyme activity and dopamine catabolism 96, 97 , with subsequent increase in the availability of dopamine 96, 98, 99 , particularly in the prefrontal cortex.
Four meta-analyses of studies of the association between the rs4680 polymorphism and OCD had discordant results. The first, carried out in 2003 100 included case-control and family-based studies and found no significant association. The second, made in 2007, only with case-control studies (n = 1,908 individuals) found an association between OCD and L allele in men but not in women 101 . This finding was replicated in the third meta-analysis that included published casecontrol and family-based studies 40 . However, a fourth meta-analysis, with only studies based on families, also found no association with OCD 102 . Studies related to the COMT are described in table 5.
A common feature among BDNF, NKTR, COMT and MAO-A is that their functions lead to neuronal pathways in various implications. The lack of specificity of their functions may contribute to the inconsistent findings in studies of these genes in association with OCD. 
White matter relatd genes
Transcription factor of the oligodendrocyte lineage (OLIG2; BHLHB1 OLIGO2, PRKCBP2, RACK17)
Chromosome: 21; location: 21q22.11
OCD is associated with decreased volume and structural abnormalities of white matter 103, 104 , reflecting a decrease in fractional anisotropy 105 . The transcription factor of the oligodendrocyte lineage 2 (OLIG2) is involved in myelination and neurogenesis and is essential in regulating the development of cells producing white substance (myelin) 106 111 . Genes related to white matter in OCD have been studied little and his findings are interesting. The evaluation of the association between these genes and the change of white matter as an OCD endophenotype, deserve to be studied more.
Immune system telated genes
There is evidence to support the involvement of the immune system in OCD, as the emergence of OCD associated with rheumatic fever [112] [113] [114] , Pediatric Autoimmune Neuropsychiatric Disease with Associated Streptococcus (PANDAS) 115, 116 and evidence that disorders of the obsessive-compulsive spectrum aggregate in families of patients with rheumatic fever [117] [118] [119] .
Tumor necrosis factor alpha (TNF-alpha) 
Interleukin-6 (IL-6)
Chromosome: 1; location: 1q21
Cappi et al. evaluated 83 trios with OCD as the rs1800795 polymorphism in the promoter region of IL-6 and found no association 122 . The TNFA was associated with OCD in two studies, but with different alleles. Therefore, this association has yet to be replicated in future studies. There is a small number of association studies of genes related to immune response and more studies are needed in this area.
Hormone-related genes
Estrogen receptor alpha (ESR)
Chromosome: 6; location: 6q25.1
There is the hypothesis that estrogen-related genes influence the clinical presentation of OCD. The postpartum period is a risk for the development of obsessive-compulsive symptoms 125 . Several clinical and genetic studies in OCD showed different results for the two genders. Among the sex steroids there is evidence that estrogens modulate monoamines and neuropeptides (including those more related to OCD such as serotonin, dopamine, glutamate and GABA) regulate emotional responses, promote neuroprotective effects and improve cognition 126 . Alonso et al. evaluated the gene estrogen receptor 1 and 2 (ESR1 and ESR2) in 236 cases with OCD and 296 healthy controls; they found that the rs34535804 SNP and haplotype of ESR1 five SNPs were significantly associated with extent of contamination/cleaning (p = 0.0001) and the frequency of the haplotype rs34535804 * A/rs488133 * C/rs9478245 * C/rs2234693 C/ rs9340799 * G * was significantly lower in patients with this symptom dimension (p = 0.018) 127 .
Studies evaluating the association of genes related to estrogen in specific subtypes of OCD, such as of early postpartum OCD or late onset OCD in females as well as the investigation of genes related to oxytocin could help in understanding the mechanisms by which there is an increased risk of developing OCD after the birth of a child or in the postpartum period [128] [129] [130] .
Discussion
There is a body of evidence that biological/genetic expression is important in OCD. The genetic segregation model that best explained OCD is the complex model in which the influences of several genes with small effects are in interaction with environmental factors. Seve ral studies with candidate genes have been performed for various reasons and their findings are not conclusive.
Possible explanations for the diversity of results and low replicability are its small sample size and the low statistical power of most studies. Moreover, many of them conducted multiple analyses without adequate statistical correction to its results, which increases the chance of false positives.
Another possible explanation for the diversity of results is the phenotypic heterogeneity of OCD. There is a hypothesis that different subgroups of TOC can receive influence from different genes. The subgroups of OCD can be organized by gender, age at onset of symptoms and comorbid tics 131, 132 . There is also an attempt to subdivide the TOC according to the size of symptoms because they would relate to a different neurobiological substrate. Hoarding, for example, has specific features on the epidemiology, treatment response in neuroimaging findings [133] [134] [135] [136] and genetic findings 137 . As for comorbid tics, there is evidence of involvement of the dopaminergic system in OCD 138 and there were even found positive findings of association between certain genes related to dopamine and OCD with comorbid tic disorders 49, 50, 57 . OCD also is genetically linked to Tourette syndrome 139, 140 which was associated with dopamine-related genes such as the gene for dopamine D2 receptor (DRD2) [141] [142] [143] , dopamine receptor D4 (DRD4) 144 , dopamine transporter (DAT) 145 , and monoamine oxidase A (MAO-A) 144 . It is possible that OCD in comorbid tic disorders configure a separate subgroup with susceptibility associated with polymorphisms in genes related to dopamine. OCD can also be heterogeneous between genders. Several genetic association studies showed there were differences when analyzed separately by gender 16, 17, 51, 85, 101, [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] . The same is seen when the sample is divided according to age at onset of TOC 18, 20, 56, 68, 86, 153, 156 . These two characteristics are used to group individuals with OCD in more homogeneous subgroups 131 .
The use of quantitative traits (such as severity scores of YBOCS), endophenotypes, studies of gene-environment interaction and epigenetic studies are the next steps in association studies in OCD. Possible investigations of interaction between genes and environment in OCD include the role of polymorphisms in the development of OCD after traumatic events, or streptococcus infection, or even the influence of polymorphisms in the development of personality traits risk for OCD 157 . The definition of endophenotypes by neuroimaging studies, neurophysiology and neuropsychology are essential in guiding genetic studies 157 .
Conclusion
The amount of available data does not allow us to pinpoint a gene responsible for the etiology of OCD. Establishing groups with more homogeneous phenotypes may improve the accuracy of results. Association studies with a large sample size, sometimes achieved through consortia and meta-analyses are still needed.
